A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

NCT06244485 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Valemetostat tosylate
DRUG: T-DXd
DRUG: Dato-DXd

Sponsor

Daiichi Sankyo